The Merkin Institute for Transformative Technologies will fund early-stage ideas for novel technological approaches to treating disease. [Source: © 4designersart/Fotolia]

Broad Institute Launches Effort to Fund Transformative Technologies

The Merkin Institute for Transformative Technologies will fund early-stage development of novel technological approaches to treating disease

RenalytixAI, UMCG to Partner on Kidney Disease Diagnostic Study

RenalytixAI will assess its lead product, the AI-enabled kidney disease diagnostic KidneyIntelX, in more than 3,500 patients with Type II diabetes through a collaboration...
Biocept will partner with University of California San Diego (UCSD) Medical Center on a clinical validation study of the company’s Target Selector™ PD-L1 assay for patients diagnosed with non-small cell lung cancer (NSCLC). [Source: andresr/Getty Images]

Biocept, UCSD Med Center Partner on Clinical Validation Study for PD-L1 Assay in NSCLC

Biocept and University of California San Diego (UCSD) Medical Center will assess the company’s Target Selector assay in NSCLC patients

Breast Cancer Care After Genetic Testing Often Doesn’t Follow Guidelines

Tracking treatment trends is important as more women are receiving genetic testing when they are diagnosed with early-stage breast cancer and treatment options are expanding.
Juvenile diabetes patient checking his blood glucose levels at home

Genetic Testing for People Diagnosed with Type 1 Diabetes Could Rule Out Disease

A new study suggests that all young people with newly diagnosed Type 1 diabetes should be tested for a genetic mutation that could be...
Seegene will partner its Allplex™ assays with Thermo Fisher Scientific’s PCR System (Source: Seegene)

Seegene Partners with Thermo Fisher Scientific to Enter U.S. Diagnostics Market

Seegene said it will partner Allplex™ assay with Thermo Fisher Scientific’s PCR System, aiming to create a comprehensive MDx solution
Coronavirus, artwork

IDbyDNA to Advance Explify Platform, Expand Commercial Operations with $20M Series B Financing

The Explify platform is designed to identify more than 50,000 microorganisms, and more than 3,000 known common and rare pathogens. The platform uses a proprietary database of curated DNA and RNA reference sequences to identify 35,000+ viruses, 13,000+ bacteria, 4,000+ fungi, and 150+ parasites.
Celsius Therapeutics

Celsius to Develop Precision Tx for Cancer, Autoimmune Diseases with Recent $65M Financing

Company will use single-cell sequencing to find cells playing key roles in disease, and identify genes causing those cells to malfunction
Source: CIPhotos/Getty Images

First Nanopore Sequencing of Human Genome Reported

Using the MinION sequencer, the ultra-long reads allow researchers to close 12 gaps in the reference genome though accuracy issues remain
Source: Tetra Images/Getty Images

Diagnomics, Translational Software Partner on Pharmacogenomic Testing Service

The PGx guide, available in the U.S., will report on an individual's anticipated drug response, metabolism and medication efficacy
Scroll Up